Who is at risk
of alpha-1 antitrypsin deficiency?
A1ATD is most common in people with European ancestry. Around 1 in 2000 people in the UK have the genes most likely to cause the condition. But many of them will never develop symptoms.
Some types of A1ATD do not normally cause problems on their own. But they can become a problem if there is another risk factor.
The information on this page is for:
- Adults and children with A1ATD. or suspected A1ATD.
- Family, friends, carers, and healthcare professionals.
On this page:
What age do people get alpha-1 antitrypsin deficiency?
A1ATD is a genetic condition. So people with it are born with the genes that cause it and have those genes all their life.
But most people are only diagnosed if they start to show symptoms. Usually of either liver or lung disease.
There are 2 age groups where A1ATD is most likely to be diagnosed.
Babies and young children
Some babies and young children will be diagnosed with A1ATD. Usually after they show signs of a liver problem in the first 2 years of life. This is usually jaundice (a yellow colour to the eyes or skin) or a swollen tummy (abdominal distension).
Some young children are not jaundiced and can be diagnosed during routine exams and blood tests.
Adults
People with lung disease caused by A1ATD are often diagnosed between 40 and 50 years old. Especially if they smoke.
People over the age of 50 have a higher risk of severe liver disease caused by A1ATD. This may be because it takes a long time for the liver damage to build up.
What increases the risk of becoming unwell because of alpha-1 antitrypsin deficiency?
Genes cause A1ATD, but not everyone with the genes will get the condition. In some cases, other risk factors are needed as well.
It is not possible to predict who will become unwell and who will not. But there are some things that we know increase the risk in adults.
Smoking
Smoking damages the lungs. It also stops the AAT protein from working properly.
Smokers with A1ATD genes are more likely to get lung diseases like COPD and emphysema. They are also more likely to get these conditions at a younger age than other smokers.
Passive smoking also seems to be a problem.
Exposure to other hazardous fumes
Breathing in other hazardous fumes, for example at work, is also riskier for people with A1ATD.
Being male
Men are more likely to develop A1ATD liver disease. It is thought that this is linked to male hormones.
Other risks:
Adults are more likely to develop serious liver problems if they have A1ATD and they:
- have diabetes
- are overweight
- have another metabolic condition
You can find out more about how to reduce the risk in the Living with A1ATD section.
Alpha-1 antitrypsin deficiency and other liver conditions
Having A1ATD can increase the risk of getting seriously ill if someone also has another liver condition.
There is evidence that having AATD increases the risk from:
- Fatty liver disease (MASLD)
- Alcohol related liver disease (ARLD)
- Cystic fibrosis related liver disease in children
There is also some evidence that A1ATD can affect long term (chronic) viral hepatitis B and C and haemochromatosis. But more research is needed to understand these links better.
In some cases, having the genes for A1ATD is only a problem when someone also has another liver condition.
Support
How Liver UK can help
A diagnosis of liver disease can be worrying, and you may have a lot of questions.
We're here for you and for your family and friends. Whether you have questions or just need someone to listen, we can help.
Your feedback
This content was last reviewed: June 2026
Our expert reviewers:
We would like to thank everyone who helped with creating and reviewing this page. Including Dr Bill Griffiths, consultant hepatologist, Cambridge university hospitals, Professor Dino Hadzic, consultant paediatric hepatologist, King’s college hospital, Dr Girish Gupte, consultant paediatric hepatologist, Birmingham children’s hospital. And all our patient and family reviewers.
Liver UK thanks Takeda UK for their kind donation to support the development of this information. Takeda UK has had no influence in the initiation, development or content of this project.
Find out how we make our patient information.
Everyone’s experience of liver disease will be different. Always talk to your specialist medical team for personal advice.
More from Liver UK

Check your risk
Find out more

Support us
Find out more

Keep up to date
Find out more